Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0210
-0.0144 (-40.68%)
Aug 29, 2025, 3:48 PM EDT
YBGJ Revenue
Yubo International Biotech had revenue of $-18.00 in the twelve months ending June 30, 2025, down -100.00% year-over-year. In the year 2024, Yubo International Biotech had annual revenue of $3.47K, down -99.43%.
Revenue (ttm)
-18.00
Revenue Growth
-100.00%
P/S Ratio
-198,824.28
Revenue / Employee
-1.00
Employees
18
Market Cap
3.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.47K | -601.21K | -99.43% |
| Dec 31, 2023 | 604.68K | 500.39K | 479.84% |
| Dec 31, 2022 | 104.28K | -1.14M | -91.62% |
| Dec 31, 2021 | 1.24M | -109.50K | -8.09% |
| Dec 31, 2020 | 1.35M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |